Clinical Trials Information Service

The Lymphoma Research Foundation’s Clinical Trials Information Service helps patients explore investigative lymphoma treatments being evaluated at cancer centers nationwide. Upon request, the Foundation’s Helpline staff can conduct a personalized search for potential clinical trials based on the medical information provided. While the Foundation does not offer medical advice or endorse specific treatments, patients are encouraged to review trial summaries with their physicians. A physician can assess the study criteria and determine whether a particular clinical trial is a suitable option.

To initiate a clinical trial search, patients must submit the following information via a request form to the Helpline staff:

• Age
• Diagnosis (lymphoma subtype).
• Types of previous treatment (if any), the dates, and the response.
• Other medical diagnoses (i.e., another cancer, HIV, diabetes).
• Geographic area willing to travel to for treatment.

Hundreds of lymphoma clinical trials are underway at hospitals, cancer centers, and doctors’ offices, often sponsored by the government, pharmaceutical companies, universities, and physician groups. These trials play a crucial role in advancing research and providing access to cutting-edge treatments. Each phase of a clinical trial must be approved by the U.S. Food and Drug Administration (FDA) and the Institutional Review Board (IRB) of the participating hospital or institution.

We provide patients with essential information to help them make informed decisions and engage in shared decision-making with their healthcare teams and families. The choice to participate in a clinical trial should be made carefully and in consultation with a patient’s healthcare team.

---

Learn More About Clinical Trials